Related Experiment Video
Updated: Jun 14, 2025

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Clinical Updates in Coronary Artery Disease: A Comprehensive Review
Andrea Bottardi1, Guy F A Prado1,2, Mattia Lunardi1,3
1Division of Cardiology, Cardio-Thoracic Department, University of Verona, 37100 Verona, Italy.
Insights
Coronary artery disease (CAD) management requires updated strategies beyond current guidelines. This review synthesizes recent advancements in non-invasive diagnostics, risk assessment, and treatments for acute and stable CAD.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Practice
Background:
- Coronary artery disease (CAD) remains a leading cause of mortality globally, despite advancements.
- Current clinical guidelines may not fully incorporate the latest research findings.
- There is a need to bridge the gap between emerging data and routine clinical practice.
Purpose of the Study:
- To provide an updated overview of recent clinical developments in coronary artery disease (CAD).
- To focus on non-invasive diagnostic techniques, risk stratification, and therapeutic interventions.
- To offer insights beyond existing guidelines for healthcare providers.
Main Methods:
- Comprehensive literature review of recent clinical updates in CAD.
- Synthesis of novel data on diagnostic and therapeutic strategies.
- Focus on both acute and stable coronary artery disease scenarios.
Main Results:
- Recent advancements in non-invasive diagnostic modalities for CAD.
- Updated approaches to risk stratification in patients with CAD.
- Emerging medical and interventional therapies for acute and stable CAD.
- Identification of data not yet integrated into current practice guidelines.
Conclusions:
- Continuous integration of new evidence is crucial for optimal CAD management.
- This review highlights key recent developments to inform clinical decision-making.
- Adopting updated strategies can improve patient outcomes and healthcare system efficiency.
Abstract:
Despite significant goals achieved in diagnosis and treatment in recent decades, coronary artery disease (CAD) remains a high mortality entity and continues to pose substantial challenges to healthcare systems globally. After the latest guidelines, novel data have emerged and have not been yet considered for routine practice. The scope of this review is to go beyond the guidelines, providing insights into the most recent clinical updates in CAD, focusing on non-invasive diagnostic techniques, risk stratification, medical management and interventional therapies in the acute and stable scenarios. Highlighting and synthesizing the latest developments in these areas, this review aims to contribute to the understanding and management of CAD helping healthcare providers worldwide.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Coronary Circulation
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Overview of Systemic Arteries
Systemic circulation is the part of the cardiovascular system that carries oxygenated blood away from the heart to the body's tissues and returns deoxygenated blood back to the...
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....

